Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1591 AL 1605

Deep Brain Stimulation Using Animal Models of Parkinson's Disease

Nakajima A, Shimo Y.

Methods Mol Biol. 2021;2322:151-160. doi: 10.1007/978-1-0716-1495-2_15.

Mechanism of Gene-Environment Interactions Driving Glial Activation in Parkinson's Diseases

Sarkar S.

Curr Environ Health Rep. 2021 Sep;8(3):203-211. doi: 10.1007/s40572-021-00320-w. Epub 2021 May 27.

An updated patent review of VEGFR-2 inhibitors (2017-present)

Farghaly TA, Al-Hasani WA, Abdulwahab HG.

Expert Opin Ther Pat. 2021 Nov;31(11):989-1007. doi: 10.1080/13543776.2021.1935872. Epub 2021 Jun 14.

Movement of prion-like α-synuclein along the gut-brain axis in Parkinson's disease: A potential target of curcumin treatment

Chetty D, Abrahams S, van Coller R, Carr J, Kenyon C, Bardien S.

Eur J Neurosci. 2021 Jul;54(2):4695-4711. doi: 10.1111/ejn.15324. Epub 2021 Jun 23.

Health Care Resource Utilization Associated With Parkinson Disease Among Medicare Beneficiaries

Gandhi AB, Onukwugha E, Albarmawi H, Johnson A, Myers DE, Gray D, Alvir J, Hynicka L, Shulman LM.

Neurology. 2021 Aug 10;97(6):e597-e607. doi: 10.1212/WNL.0000000000012290. Epub 2021 May 27.

Microglial Exosomes in Neurodegenerative Disease

Guo M, Hao Y, Feng Y, Li H, Mao Y, Dong Q, Cui M.

Front Mol Neurosci. 2021 May 11;14:630808. doi: 10.3389/fnmol.2021.630808. eCollection 2021.

Aerobic Exercise Combined With Transcranial Direct Current Stimulation Over the Prefrontal Cortex in Parkinson Disease: Effects on Cortical Activity, Gait, and Cognition

Conceição NR, Gobbi LTB, Nóbrega-Sousa P, Orcioli-Silva D, Beretta VS, Lirani-Silva E, Okano AH, Vitório R.

Neurorehabil Neural Repair. 2021 Aug;35(8):717-728. doi: 10.1177/15459683211019344. Epub 2021 May 28.

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Vitalakumar D, Sharma A, Flora SJS.

J Biochem Mol Toxicol. 2021 Aug;35(8):e22830. doi: 10.1002/jbt.22830. Epub 2021 May 28.

Understanding amphisomes

Ganesan D, Cai Q.

Biochem J. 2021 May 28;478(10):1959-1976. doi: 10.1042/BCJ20200917.

Mechanisms of Antiparkinsonian Anticholinergic Therapy Revisited

Paz RM, Murer MG.

Neuroscience. 2021 Jul 15;467:201-217. doi: 10.1016/j.neuroscience.2021.05.026. Epub 2021 May 25.

The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations

York MK, Farace E, Pollak L, Floden D, Lin G, Wyman-Chick K, Bobholz J, Palmese CA, Racine C, Tran B, Turner TH, Jimenez-Shahed J; of the Parkinson Study Group Functional Neurosurgical Working Group.

Parkinsonism Relat Disord. 2021 May;86:135-138. doi: 10.1016/j.parkreldis.2021.04.029. Epub 2021 May 14.

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study

Vijiaratnam N, Girges C, Auld G, Chau M, Maclagan K, King A, Skene S, Chowdhury K, Hibbert S, Morris H, Limousin P, Athauda D, Carroll CB, Hu MT, Silverdale M, Duncan GW, Chaudhuri R, Lo C, Del Din S, Yarnall AJ, Rochester L, Gibson R, Dickson J, Hunter R, Libri V, Foltynie T.

BMJ Open. 2021 May 28;11(5):e047993. doi: 10.1136/bmjopen-2020-047993.

Emerging Materials and Technologies with Applications in Flexible Neural Implants: A Comprehensive Review of Current Issues with Neural Devices

Cho Y, Park S, Lee J, Yu KJ.

Adv Mater. 2021 Nov;33(47):e2005786. doi: 10.1002/adma.202005786. Epub 2021 May 29.

The effects of bright light therapy on depression and sleep disturbances in patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

Lin F, Su Y, Weng Y, Lin X, Weng H, Cai G, Cai G.

Sleep Med. 2021 Jul;83:280-289. doi: 10.1016/j.sleep.2021.03.035. Epub 2021 Apr 3.

Connecting the dots between mitochondrial dysfunction and Parkinson's disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity

Kaur I, Behl T, Sehgal A, Singh S, Sharma N, Aleya L, Bungau S.

Environ Sci Pollut Res Int. 2021 Jul;28(28):37060-37081. doi: 10.1007/s11356-021-14619-6. Epub 2021 May 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias